Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model.

Martin FP, Wang Y, Sprenger N, Yap IK, Lundstedt T, Lek P, Rezzi S, Ramadan Z, van Bladeren P, Fay LB, Kochhar S, Lindon JC, Holmes E, Nicholson JK.

Mol Syst Biol. 2008;4:157. doi: 10.1038/msb4100190. Epub 2008 Jan 15.

2.

Positive interactions with the microbiota: probiotics.

Kalliomäki M, Salminen S, Isolauri E.

Adv Exp Med Biol. 2008;635:57-66. doi: 10.1007/978-0-387-09550-9_5. Review.

PMID:
18841703
3.

The potential for probiotic manipulation of the gastrointestinal microbiome.

Rauch M, Lynch SV.

Curr Opin Biotechnol. 2012 Apr;23(2):192-201. doi: 10.1016/j.copbio.2011.11.004. Epub 2011 Nov 30. Review.

PMID:
22137452
4.

The gut microbiome as therapeutic target.

Cani PD, Delzenne NM.

Pharmacol Ther. 2011 May;130(2):202-12. doi: 10.1016/j.pharmthera.2011.01.012. Epub 2011 Feb 2. Review.

PMID:
21295072
5.

The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.

Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, de Vos WM, Groen AK, Hoekstra JB, Stroes ES, Nieuwdorp M.

Diabetes Obes Metab. 2012 Feb;14(2):112-20. doi: 10.1111/j.1463-1326.2011.01483.x. Epub 2011 Nov 22. Review.

PMID:
21812894
6.

Probiotic (symbiotic) bacterial languages.

Shenderov BA.

Anaerobe. 2011 Dec;17(6):490-5. doi: 10.1016/j.anaerobe.2011.05.009. Epub 2011 May 23. Review.

PMID:
21624483
7.

Gut microbiome and nonalcoholic fatty liver diseases.

Zhu L, Baker RD, Baker SS.

Pediatr Res. 2015 Jan;77(1-2):245-51. doi: 10.1038/pr.2014.157. Epub 2014 Oct 13. Review.

PMID:
25310763
8.

Immunology and probiotic impact of the newborn and young children intestinal microflora.

Bezirtzoglou E, Stavropoulou E.

Anaerobe. 2011 Dec;17(6):369-74. doi: 10.1016/j.anaerobe.2011.03.010. Epub 2011 Apr 16. Review.

PMID:
21515397
9.

Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm.

Walter J, Britton RA, Roos S.

Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4645-52. doi: 10.1073/pnas.1000099107. Epub 2010 Jun 25. Review.

10.

Therapeutic modulation of microbiota-host metabolic interactions.

Holmes E, Kinross J, Gibson GR, Burcelin R, Jia W, Pettersson S, Nicholson JK.

Sci Transl Med. 2012 Jun 6;4(137):137rv6. doi: 10.1126/scitranslmed.3004244. Review.

PMID:
22674556
11.

An intimate tête-à-tête - how probiotic lactobacilli communicate with the host.

Remus DM, Kleerebezem M, Bron PA.

Eur J Pharmacol. 2011 Sep;668 Suppl 1:S33-42. doi: 10.1016/j.ejphar.2011.07.012. Epub 2011 Jul 27. Review.

PMID:
21816142
12.

Companion animals symposium: humanized animal models of the microbiome.

Gootenberg DB, Turnbaugh PJ.

J Anim Sci. 2011 May;89(5):1531-7. doi: 10.2527/jas.2010-3371. Epub 2010 Sep 10. Review.

13.

The quest for probiotic effector molecules--unraveling strain specificity at the molecular level.

Lee IC, Tomita S, Kleerebezem M, Bron PA.

Pharmacol Res. 2013 Mar;69(1):61-74. doi: 10.1016/j.phrs.2012.09.010. Epub 2012 Oct 8. Review.

PMID:
23059538
14.

The development of probiotic treatment in obesity: a review.

Mekkes MC, Weenen TC, Brummer RJ, Claassen E.

Benef Microbes. 2014 Mar;5(1):19-28. doi: 10.3920/BM2012.0069. Review.

PMID:
23886977
15.

Gut microbiota and obesity.

Krznarić Z, Vranešić Bender D, Kunović A, Kekez D, Stimac D.

Dig Dis. 2012;30(2):196-200. doi: 10.1159/000336965. Epub 2012 Jun 20. Review. Retraction in: Dig Dis. 2014;32(3):314.

PMID:
22722438
16.

Traditional Chinese medicine: balancing the gut ecosystem.

Li H, Zhou M, Zhao A, Jia W.

Phytother Res. 2009 Sep;23(9):1332-5. doi: 10.1002/ptr.2590. Review.

PMID:
19253310
17.

Understanding the role of gut microbiome-host metabolic signal disruption in health and disease.

Holmes E, Li JV, Athanasiou T, Ashrafian H, Nicholson JK.

Trends Microbiol. 2011 Jul;19(7):349-59. doi: 10.1016/j.tim.2011.05.006. Epub 2011 Jun 22. Review.

PMID:
21684749
18.

Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota.

Cani PD, Delzenne NM.

Curr Opin Pharmacol. 2009 Dec;9(6):737-43. doi: 10.1016/j.coph.2009.06.016. Epub 2009 Jul 21. Review.

PMID:
19628432
19.

The Gut Microbiota and Nonalcoholic Fatty Liver Disease.

Quigley EM, Monsour HP.

Semin Liver Dis. 2015 Aug;35(3):262-9. doi: 10.1055/s-0035-1562946. Epub 2015 Sep 17. Review.

PMID:
26378643
20.

Probiotic mechanisms of action.

Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A.

Ann Nutr Metab. 2012;61(2):160-74. doi: 10.1159/000342079. Epub 2012 Oct 2. Review.

Supplemental Content

Support Center